← Back to Search

Virtual Exercise Program for Breast Cancer

N/A
Waitlist Available
Led By Kristin L Campbell, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at week 8 (end of intervention), 16 weeks and 12-months
Awards & highlights

Study Summary

This trial will test how well an 8-week virtual exercise program works to improve physical function for people with breast cancer receiving endocrine therapy.

Who is the study for?
The BE-FIT trial is for English-speaking individuals with Stage I-III breast cancer who have finished primary treatments and are currently on endocrine therapy (Tamoxifen or an Aromatase Inhibitor) for at least 3 months but not more than 3 years. Participants must have internet access and a device with a camera to attend virtual exercise classes.Check my eligibility
What is being tested?
This study tests the effectiveness of an 8-week virtual exercise program designed to improve physical function in those undergoing endocrine therapy for breast cancer. It involves twice-weekly group classes via Zoom, plus independent home exercises, with evaluations over a year.See study design
What are the potential side effects?
Since this trial focuses on an exercise program, side effects may include typical post-exercise symptoms such as muscle soreness or fatigue. However, these are generally mild and temporary.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at week 8 (end of intervention), 16 weeks and 12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at week 8 (end of intervention), 16 weeks and 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Body mass index
Health-related quality of life
Height in metres
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Immediate Intervention GroupExperimental Treatment1 Intervention
The intervention is an 8-week combined aerobic and resistance program, with virtual, group-based, supervised exercise sessions twice per week (60 min). The intervention also includes optional education on healthy eating.
Group II: Delayed Intervention GroupExperimental Treatment1 Intervention
Usual lifestyle control for 8 weeks and then invited to participate in the exercise intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Immediate Intervention Group
2013
N/A
~350
Delayed Intervention Group
2007
N/A
~310

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,466,829 Total Patients Enrolled
14 Trials studying Breast Cancer
3,045 Patients Enrolled for Breast Cancer
British Columbia Cancer AgencyOTHER
171 Previous Clinical Trials
90,379 Total Patients Enrolled
18 Trials studying Breast Cancer
7,986 Patients Enrolled for Breast Cancer
Kristin L Campbell, PhDPrincipal InvestigatorDepartment of Physical Therapy
3 Previous Clinical Trials
142 Total Patients Enrolled
1 Trials studying Breast Cancer
27 Patients Enrolled for Breast Cancer

Media Library

Immediate Intervention Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT04824339 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent has the participant pool increased for this research endeavor?

"Affirmative, the data posted on clinicaltrials.gov demonstrate that this research is in search of participants. It was first advertised on 15th March 2021 and has since been updated 26 days later. This study requires 132 individuals from one particular medical centre to partake."

Answered by AI

Who is able to partake in this clinical study?

"This clinical trial seeks 132 individuals aged 19 - 75 with a diagnosis of breast cancer who have completed primary treatment such as surgery, radiation and/or chemotherapy. Further requirements include receiving adjuvant endocrine therapy (Tamoxifen or Aromatase Inhibitor) for at least three months to allow acclimation; being literate in English; and having access to technology equipped with video capabilities like tablets, smartphones, laptops or computers."

Answered by AI

Are participants of this research study limited to those over 20 years of age?

"This research project is seeking participants aged 19 and over, up to 75 years old."

Answered by AI

Is recruitment still active for this investigation?

"Affirmative, according to clinicaltrials.gov, this medical experiment is currently recruiting participants. Initially posted on March 15th 2021, the study was last edited on March 26th and requires 132 patients from a single site."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
Clinical Exercise Physiology Lab
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.
Kristin Campbell 2021. "Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04824339.
~32 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top